128 related articles for article (PubMed ID: 16417967)
1. Manganese induces inducible nitric oxide synthase (iNOS) expression via activation of both MAP kinase and PI3K/Akt pathways in BV2 microglial cells.
Bae JH; Jang BC; Suh SI; Ha E; Baik HH; Kim SS; Lee MY; Shin DH
Neurosci Lett; 2006 May; 398(1-2):151-4. PubMed ID: 16417967
[TBL] [Abstract][Full Text] [Related]
2. c-Jun N-terminal kinase and p38 mitogen-activated protein kinase mediate double-strand RNA-induced inducible nitric oxide synthase expression in microglial cells.
Kong PJ; Lee HJ; Lee SH; Kim SY; Lee SN; Chun WJ; Kim SS
Neurosci Lett; 2008 Mar; 433(3):215-8. PubMed ID: 18258363
[TBL] [Abstract][Full Text] [Related]
3. Catalase induced expression of inflammatory mediators via activation of NF-kappaB, PI3K/AKT, p70S6K, and JNKs in BV2 microglia.
Jang BC; Paik JH; Kim SP; Shin DH; Song DK; Park JG; Suh MH; Park JW; Suh SI
Cell Signal; 2005 May; 17(5):625-33. PubMed ID: 15683737
[TBL] [Abstract][Full Text] [Related]
4. Catalase induces the expression of inducible nitric oxide synthase through activation of NF-kappaB and PI3K signaling pathway in Raw 264.7 cells.
Jang BC; Paik JH; Kim SP; Bae JH; Mun KC; Song DK; Cho CH; Shin DH; Kwon TK; Park JW; Park JG; Baek WK; Suh MH; Lee SH; Baek SH; Lee IS; Suh SI
Biochem Pharmacol; 2004 Dec; 68(11):2167-76. PubMed ID: 15498507
[TBL] [Abstract][Full Text] [Related]
5. Baicalein suppresses hypoxia-induced HIF-1alpha protein accumulation and activation through inhibition of reactive oxygen species and PI 3-kinase/Akt pathway in BV2 murine microglial cells.
Hwang KY; Oh YT; Yoon H; Lee J; Kim H; Choe W; Kang I
Neurosci Lett; 2008 Oct; 444(3):264-9. PubMed ID: 18771709
[TBL] [Abstract][Full Text] [Related]
6. Tetramethylpyrazine inhibits production of nitric oxide and inducible nitric oxide synthase in lipopolysaccharide-induced N9 microglial cells through blockade of MAPK and PI3K/Akt signaling pathways, and suppression of intracellular reactive oxygen species.
Liu HT; Du YG; He JL; Chen WJ; Li WM; Yang Z; Wang YX; Yu C
J Ethnopharmacol; 2010 Jun; 129(3):335-43. PubMed ID: 20371283
[TBL] [Abstract][Full Text] [Related]
7. Fructose-1,6-bisphosphate attenuates induction of nitric oxide synthase in microglia stimulated with lipopolysaccharide.
Kim YC; Park TY; Baik E; Lee SH
Life Sci; 2012 Feb; 90(9-10):365-72. PubMed ID: 22227475
[TBL] [Abstract][Full Text] [Related]
8. Withaferin A inhibits iNOS expression and nitric oxide production by Akt inactivation and down-regulating LPS-induced activity of NF-kappaB in RAW 264.7 cells.
Oh JH; Lee TJ; Park JW; Kwon TK
Eur J Pharmacol; 2008 Dec; 599(1-3):11-7. PubMed ID: 18838070
[TBL] [Abstract][Full Text] [Related]
9. PI3K/AKT, JNK, and ERK pathways are not crucial for the induction of cholesterol biosynthesis gene transcription in intestinal epithelial cells following treatment with the potato glycoalkaloid alpha-chaconine.
Mandimika T; Baykus H; Poortman J; Garza C; Kuiper H; Peijnenburg A
J Agric Food Chem; 2008 Sep; 56(18):8745-52. PubMed ID: 18729378
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-induced iNOS expression in microglia is regulated by the PI3-kinase/Akt/mTOR signaling pathway and activation of hypoxia inducible factor-1alpha.
Lu DY; Liou HC; Tang CH; Fu WM
Biochem Pharmacol; 2006 Oct; 72(8):992-1000. PubMed ID: 16919605
[TBL] [Abstract][Full Text] [Related]
11. LPS-induced iNOS expression in Bv-2 cells is suppressed by an oxidative mechanism acting on the JNK pathway--a potential role for neuroprotection.
Svensson C; Fernaeus SZ; Part K; Reis K; Land T
Brain Res; 2010 Mar; 1322():1-7. PubMed ID: 20138851
[TBL] [Abstract][Full Text] [Related]
12. IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways.
Kim YJ; Hwang SY; Oh ES; Oh S; Han IO
J Neurosci Res; 2006 Oct; 84(5):1037-46. PubMed ID: 16881054
[TBL] [Abstract][Full Text] [Related]
13. Signal transduction pathways of nitric oxide release in primary microglial culture challenged with gram-positive bacterial constituent, lipoteichoic acid.
Chien HF; Yeh KY; Jiang-Shieh YF; Wei IH; Chang CY; Chang ML; Wu CH
Neuroscience; 2005; 133(2):423-36. PubMed ID: 15878805
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of p38 mitogen-activated protein kinase enhances c-Jun N-terminal kinase activity: implication in inducible nitric oxide synthase expression.
Lahti A; Sareila O; Kankaanranta H; Moilanen E
BMC Pharmacol; 2006 Feb; 6():5. PubMed ID: 16504051
[TBL] [Abstract][Full Text] [Related]
15. Excretory-secretory products from Paragonimus westermani increase nitric oxide production in microglia in PKC-dependent and -independent manners.
Jin Y; Choi IY; Kim C; Hong S; Kim WK
Neurosci Res; 2009 Oct; 65(2):141-7. PubMed ID: 19539668
[TBL] [Abstract][Full Text] [Related]
16. Differential requirement of signal pathways for benzo[a]pyrene (B[a]P)-induced nitric oxide synthase (iNOS) in rat esophageal epithelial cells.
Chen J; Yan Y; Li J; Ma Q; Stoner GD; Ye J; Huang C
Carcinogenesis; 2005 Jun; 26(6):1035-43. PubMed ID: 15718251
[TBL] [Abstract][Full Text] [Related]
17. Induction of COX-2 in human airway cells by manganese: role of PI3K/PKB, p38 MAPK, PKCs, Src, and glutathione depletion.
Jang BC
Toxicol In Vitro; 2009 Feb; 23(1):120-6. PubMed ID: 19084589
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB, JNK and p38 MAPK inactivation.
Zhou HY; Shin EM; Guo LY; Youn UJ; Bae K; Kang SS; Zou LB; Kim YS
Eur J Pharmacol; 2008 May; 586(1-3):340-9. PubMed ID: 18378223
[TBL] [Abstract][Full Text] [Related]
19. ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury.
Xu Z; Wang BR; Wang X; Kuang F; Duan XL; Jiao XY; Ju G
Life Sci; 2006 Oct; 79(20):1895-905. PubMed ID: 16978658
[TBL] [Abstract][Full Text] [Related]
20. Ent-pimara-8(14), 15-dien-19-oic acid isolated from the roots of Aralia cordata inhibits induction of inflammatory mediators by blocking NF-kappaB activation and mitogen-activated protein kinase pathways.
Kang OH; Chae HS; Choi JG; Oh YC; Lee YS; Kim JH; Seung MJ; Jang HJ; Bae KH; Lee JH; Shin DW; Kwon DY
Eur J Pharmacol; 2008 Dec; 601(1-3):179-85. PubMed ID: 18938152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
